<\/a><\/p>\n

NEW YORK\u2014Saying he could vouch for the quality of every one of his company\u2019s products, Eli Lilly pharmaceutical sales representative Geoffrey Klein reportedly assured a local primary care physician Thursday that he personally tries every single drug he promotes.<\/p>\n

\u201cI\u2019ve sampled each one of these, from the statins to the protease inhibitors, and I can honestly tell you that they\u2019re all top-notch,\u201d said Klein, adding that he only had positive things to say after trying out the osteoporosis medication Evista and the diabetes treatment Humulin.<\/p>\n

\u201cLook, I popped a 100-milligram Seconal tablet a few hours ago before I came here, and I have to say, so far so good.<\/p>\n

And that one for pediatric growth disorders does a bang-up job. Trust me, I know what I\u2019m talking about.\u201d<\/p>\n

At press time, Klein reportedly admitted that he had tried Bristol-Myers Squibb\u2019s cancer drug Sprycel and was underwhelmed.<\/p>\n

 <\/p>\n

Via Theonion.com<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

NEW YORK\u2014Saying he could vouch for the quality of every one of his company\u2019s products, Eli Lilly pharmaceutical sales representative Geoffrey Klein reportedly assured a local primary care physician Thursday that he personally tries every single drug he promotes. \u201cI\u2019ve sampled each one of these, from the statins to the protease inhibitors, and I can […] More<\/a><\/p>\n","protected":false},"author":4,"featured_media":1386,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[88],"tags":[203],"adace-sponsor":[],"jetpack_featured_media_url":"http:\/\/vaticanenquirer.com\/wp-content\/uploads\/2015\/04\/med-rep-trial.jpg","jetpack_publicize_connections":[],"wps_subtitle":"","_links":{"self":[{"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/posts\/1385"}],"collection":[{"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/comments?post=1385"}],"version-history":[{"count":1,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/posts\/1385\/revisions"}],"predecessor-version":[{"id":1387,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/posts\/1385\/revisions\/1387"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/media\/1386"}],"wp:attachment":[{"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/media?parent=1385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/categories?post=1385"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/tags?post=1385"},{"taxonomy":"adace-sponsor","embeddable":true,"href":"http:\/\/vaticanenquirer.com\/wp-json\/wp\/v2\/adace-sponsor?post=1385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}